In advanced CRC, increased TGF-β levels are associated with poor prognosis due to the induction of Smad2 accumulation in tumor stromal cells, which results in increased survival of metastatic cells and organ colonization [13]. This evidence concerns the gene TGFB1 and colorectal carcinoma.